Novo Nordisk A/S (BKK:NOVOB80)

Novo Nordisk Ratios and Metrics

Market cap in millions THB. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 6, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	6,846,882	7,165,453	13,209,364	15,867,615	10,523,708	8,506,891
Market Cap Growth	-43.90%	-45.76%	-16.75%	50.78%	23.71%	74.78%
Enterprise Value	7,362,211	7,505,723	13,124,032	15,760,255	10,466,570	8,396,976
Last Close Price	1.57	1.64	2.96	-	-	-
PE Ratio	13.48	14.11	27.45	37.19	38.16	35.07
PS Ratio	4.47	4.68	9.55	13.40	11.97	11.90
PB Ratio	7.12	7.45	19.32	29.21	25.38	23.68
P/TBV Ratio	21.58	22.58	84.87	67.43	65.10	60.74
P/FCF Ratio	23.42	24.51	37.56	37.45	31.75	34.42
P/OCF Ratio	11.60	12.13	22.92	28.58	26.86	30.45
EV/Sales Ratio	4.81	4.90	9.49	13.31	11.91	11.74
EV/EBITDA Ratio	9.59	9.88	18.91	27.92	25.98	25.93
EV/EBIT Ratio	10.57	10.77	19.83	29.53	27.87	27.92
EV/FCF Ratio	25.18	25.68	37.32	37.20	31.57	33.97
Debt / Equity Ratio	0.68	0.68	0.72	0.25	0.31	0.38
Debt / EBITDA Ratio	0.85	0.85	0.70	0.24	0.31	0.41
Debt / FCF Ratio	2.22	2.22	1.39	0.33	0.39	0.55
Asset Turnover	0.61	0.61	0.75	0.84	0.81	0.83
Inventory Turnover	1.20	1.20	1.20	1.26	1.29	1.24
Quick Ratio	0.54	0.54	0.53	0.62	0.67	0.65
Current Ratio	0.80	0.80	0.74	0.82	0.90	0.86
Return on Equity (ROE)	60.70%	60.70%	80.77%	88.07%	72.00%	71.24%
Return on Assets (ROA)	17.43%	17.43%	22.26%	23.55%	21.69%	21.81%
Return on Invested Capital (ROIC)	41.13%	42.60%	68.23%	88.56%	73.42%	67.98%
Return on Capital Employed (ROCE)	43.00%	43.00%	56.00%	72.30%	62.80%	62.30%
Earnings Yield	7.42%	7.09%	3.64%	2.69%	2.62%	2.85%
FCF Yield	4.27%	4.08%	2.66%	2.67%	3.15%	2.90%
Dividend Yield	2.62%	3537.08%	1834.07%	-	-	-
Payout Ratio	50.53%	50.53%	43.71%	37.96%	45.57%	45.05%
Buyback Yield / Dilution	0.34%	0.34%	0.71%	1.10%	1.34%	1.58%
Total Shareholder Return	2.96%	3537.43%	1834.78%	1.10%	1.34%	1.58%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.